• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性凝血病中血液成分的支持:这种疯狂是否有方法可循?

Blood component support in acquired coagulopathic conditions: is there a method to the madness?

机构信息

Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, Texas 75390-9073, USA.

出版信息

Am J Hematol. 2012 May;87 Suppl 1:S56-62. doi: 10.1002/ajh.23179. Epub 2012 Mar 31.

DOI:10.1002/ajh.23179
PMID:22473878
Abstract

Acquired coagulopathies are often detected by laboratory investigation in clinical practice. There is a poor correlation between mild to moderate abnormalities of laboratory test and bleeding tendency. Patients who are bleeding due to coagulopathy are often managed with various blood components including plasma, platelets, and cryoprecipitate. However, prophylactic transfusion of these products in a nonbleeding patient to correct mild to moderate abnormality of a coagulation test especially preprocedure is not evidence-based. This article reviews the management of bleeding due to oral anticoagulants and antiplatelet agents, disseminated intravascular coagulation, chronic liver disease, and trauma.

摘要

获得性凝血障碍在临床实践中常通过实验室检查发现。实验室检查中轻度至中度异常与出血倾向之间相关性差。因凝血障碍而出血的患者通常使用各种血液成分(包括血浆、血小板和冷沉淀)进行治疗。然而,对于无出血的患者预防性输注这些产品以纠正凝血试验中的轻度至中度异常(特别是术前),尚无证据支持。本文回顾了口服抗凝剂和抗血小板药物、弥漫性血管内凝血、慢性肝病和创伤导致的出血的处理方法。

相似文献

1
Blood component support in acquired coagulopathic conditions: is there a method to the madness?获得性凝血病中血液成分的支持:这种疯狂是否有方法可循?
Am J Hematol. 2012 May;87 Suppl 1:S56-62. doi: 10.1002/ajh.23179. Epub 2012 Mar 31.
2
Acute generalized, widespread bleeding. Diagnosis and management.急性全身性广泛出血。诊断与处理
Haematologica. 1998 Nov;83(11):1024-37.
3
[Blood transfusion and adjunctive therapy in the bleeding trauma patient].[出血性创伤患者的输血及辅助治疗]
Transfus Clin Biol. 2008 Nov;15(5):240-5. doi: 10.1016/j.tracli.2008.09.010. Epub 2008 Oct 17.
4
Transfusion therapy in acquired coagulopathies.获得性凝血障碍的输血治疗。
Hematol Oncol Clin North Am. 1994 Dec;8(6):1181-201.
5
[Coagulation failure: diagnosis, management and therapeutic consequences].[凝血功能衰竭:诊断、管理及治疗后果]
Dtsch Med Wochenschr. 2006 Nov 3;131(44):2482-4. doi: 10.1055/s-2006-955036.
6
Management of acquired coagulopathy in acute paediatrics.小儿急性获得性凝血病的管理
Arch Dis Child Educ Pract Ed. 2011 Apr;96(2):49-60. doi: 10.1136/adc.2007.135749. Epub 2010 Sep 27.
7
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.弥散性血管内凝血诊断与管理指南。英国血液学标准委员会。
Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12.
8
Acquired coagulation disorders.获得性凝血障碍
Clin Haematol. 1985 Jun;14(2):413-42.
9
Pediatric hemostasis and use of plasma components.小儿止血与血浆成分的应用
Best Pract Res Clin Haematol. 2006;19(1):143-55. doi: 10.1016/j.beha.2005.03.006.
10
Are we giving enough coagulation factors during major trauma resuscitation?在重大创伤复苏过程中,我们给予的凝血因子足够吗?
Am J Surg. 2005 Sep;190(3):479-84. doi: 10.1016/j.amjsurg.2005.03.034.

引用本文的文献

1
Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy.难治性凝血病背景下药物诱导的因子V抑制
Hematol Rep. 2022 Sep 21;14(4):290-293. doi: 10.3390/hematolrep14040041.
2
Effect of FFP Transfusion on International Normalized Ratio in Liver Disease Patients.新鲜冰冻血浆输注对肝病患者国际标准化比值的影响。
Indian J Hematol Blood Transfus. 2018 Oct;34(4):719-722. doi: 10.1007/s12288-018-0934-0. Epub 2018 Mar 3.